A study on safety and efficacy of Deferasirox, an oral iron chelator in the treatment of transfusion haemosiderosis in children with β-Thalassemia Major in a tertiary care rural hospital
Journal Title: Journal of Medical Science And clinical Research - Year 2018, Vol 6, Issue 8
Abstract
Background: β-Thalassemia major is a hereditary hemolytic anaemia (and the commonest transfusion dependent anaemia) which continues to be a major cause of morbidity and mortality in developing countries like India. Deferasirox is a tridentate, once-daily, oral iron chelator that is widely used in the management of patients with transfusion haemosiderosis. Chelation therapy is usually started after 10-20 transfusions or when serum ferritin level reaches 1000 μg/L [Deferasirox has demonstrated consistent dose-dependent efficacy, producing sustained reductions in serum ferritin 6]. Aims and objective Aim: To study the safety and efficacy of Deferasirox in transfusion haemosiderosis in children with βThalassemia. Objectives 1. To assess the serum ferritin levels in multi-transfused β-Thalassemia patients who are on treatment with Deferasirox. 2. To study the efficacy of Deferasirox in patients admitted with transfusion haemosiderosis in β-Thalassemia. 3. To estimate iron overload in the patients admitted with transfusion haemosiderosis in β-Thalassemia. 4. To study the adverse effect profile andfinal outcome of administration of Deferasirox in patients with transfusion haemosiderosis in β-Thalassemia. Study Period: 6 months (After the approval from IEC- RMC) Sample Size: 100Results and Observation there was adecrease in serum ferritin from 4049.87ng/ml to 3647.4ng/ml this was a significant change with a p value 0f 0.0001. Furthermore, a significant negative correlation was observed between the mean dose of deferasirox prescribed and the mean serum ferritin levels. %). Diarrhoea was reported as the most common) in our study it was found that the mean change in the serum creatinine values increased from 0.475 to0.487(table7) in our study this change was not significant(table6)the findings for sodium and serum potassium were not considered significant (table 7 and 8) in our study .awareness among prescribers about ADRs of deferasirox and frequent monitoring of serum ferritin and serum iron levels as a guide to determine its dose is required to improve tolerability of this important and necessary drug.further multi-centered studies with more sample size are needed.
Authors and Affiliations
Dr Sanjay Shukla
Keywords
Related Articles
- EP ID EP489682
- DOI -
- Views 53
- Downloads 0
Intraperitoneal Hydrocortisone plus Bupivacaine Administration for Pain Relief after Laparoscopic Cholecystectomy, a Comparison with Bupivacaine Alone
Background: Laparoscopic Cholecystectomy (LC) has become the gold standard for treatment of benign Gall Bladder disease. Laparoscopy provides many benefits over conventional open procedures including faster recovery time...
Hairy Cell Leukemia – Variant (HCL-V): A Separate Entity
A female, aged 65 years had splenomegaly and atypical lymphocytes in blood smear. Atypical cells had large round nuclei. Flow cytometric (FCM ) findings revealed positivity of atypical cells for CD19, CD103 and CD11c ant...
Incidence and trend of Carcinoma Lung among women and use of oral TKI – A Single Institution Based Study
Lung cancer is the most common cancer of men in India, whereas it is 2nd most common in women in India as per Globocon 18 data. Smoking tobacco is the principal risk factor for causation of lung cancer. However causation...
Dermatophytosis in the Sub-Himalayan region – Is Epidermophyton fluccosum Re-emerging?
Dermatophytosis is a common cutaneous condition affecting humans and animals. The causative agents are keratinophilic fungi of three genera, Trichophyton, Microsporum and Epidermophyton. Epidermophyton sp. is exceptional...
Pott’s Spine – A Rarity in Nonagenarian
Introduction Pott disease or Pott's disease is a form of tuberculosis that occurs in the vertebrae. It constitutes about 50% of all cases of tuberculosis of bones and joints. Pott’s disease results from haematogeno...